HSD17B13 and metabolic dysfunction-associated steatohepatitis: ,351 Furthermore, AdV-mediated overexpression of human HSD17B13 led to a fatty liver phenotype in mice,348 highlighting its role in promoting NAFLD/NASH pathogenesis.